EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Comment on “Ginsenoside Rk3 is a novel PI3K/AKT-targeting therapeutics agent that regulates autophagy and apoptosis in hepatocellular carcinoma”

Zhaoxian Yan, Jing Hong, Changquan Ling

Journal of Pharmaceutical Analysis · 2026-11 · 101831

DOI: 10.1016/j.jpha.2026.101831 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical Analysis, 2026-11. Verfasst von Zhaoxian Yan und 2 weiteren Autor:innen. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Yan, Z., Hong, J., & Ling, C. (2026). Comment on “Ginsenoside Rk3 is a novel PI3K/AKT-targeting therapeutics agent that regulates autophagy and apoptosis in hepatocellular carcinoma”. Journal of Pharmaceutical Analysis, 101831. https://doi.org/10.1016/j.jpha.2026.101831

Vancouver

Yan Z, Hong J, Ling C. Comment on “Ginsenoside Rk3 is a novel PI3K/AKT-targeting therapeutics agent that regulates autophagy and apoptosis in hepatocellular carcinoma”. Journal of Pharmaceutical Analysis. 2026:101831. doi:10.1016/j.jpha.2026.101831

BibTeX
@article{Yan2026,
  author = {Yan, Zhaoxian and Hong, Jing and Ling, Changquan},
  title = {Comment on “Ginsenoside Rk3 is a novel PI3K/AKT-targeting therapeutics agent that regulates autophagy and apoptosis in hepatocellular carcinoma”},
  journal = {Journal of Pharmaceutical Analysis},
  year = {2026},
  pages = {101831},
  doi = {10.1016/j.jpha.2026.101831}
}
Kostenlos starten →